Individuals With Serious Mental Illness Leaving Jails Clinical Trial
Official title:
Peer Navigation for Individuals With Serious Mental Illness Leaving Jail
| Verified date | July 2023 |
| Source | Michigan State University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Serious mental illness (SMI) is a burdensome and widely prevalent public health problem among incarcerated men and women. Incarcerated individuals with SMI re-entering the community after jail stay experience the double stigma of criminal justice involvement and having the diagnosis of SMI. As a result, they are likely to disengage with community level mental health, medical care and substance use services at re-entry. This study proposes the development and pilot test of peer navigator intervention to increase linkages to community level mental health, medical care and substance use services.
| Status | Recruiting |
| Enrollment | 40 |
| Est. completion date | April 1, 2024 |
| Est. primary completion date | January 1, 2024 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - Incarcerated in the Genesee County Jail, - Aged 18 or above, - Has a lifetime DSM-5 diagnosis of SMI (including primary psychotic disorder [schizophrenia, schizoaffective disorder, or delusional disorder], bipolar disorder, and/or a major depressive disorder with psychotic features) as assessed by the Structured Clinical Interview for DSM-5 (SCID-5) and - Anticipating release in the following two months. Exclusion Criteria: - Expect to be sentenced to prison (i.e., expect to go directly to prison, not home, from the jail), - Cannot provide the name and contact information of at least two locator persons and/or - Do not have access to any telephone. |
| Country | Name | City | State |
|---|---|---|---|
| United States | Genesee County Jail | Flint | Michigan |
| Lead Sponsor | Collaborator |
|---|---|
| Michigan State University | Brown University |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Feasibility: Client Satisfaction | Client Satisfaction Questionnaire- 8: scores range from 8-32, higher scores indicating higher satisfaction | 6 months after release | |
| Primary | Feasibility: End of treatment | End of Treatment Questionnaire: this is a descriptive measure, positive experiences described meaning higher feasibility of the service | 6 months after release | |
| Primary | Acceptability: Client Satisfaction Questionnaire | Client Satisfaction Questionnaire- 8: scores range from 8-32, higher scores indicating higher satisfaction | 6 months after release | |
| Primary | Acceptability: End of treatment | End of Treatment Questionnaire this is a descriptive measure, positive experiences described meaning better acceptability of the treatment | 6 months after release | |
| Secondary | Service linkage outcomes | Number of visits to outpatient as assessed by Treatment History Interview | Baseline, 3 months and 6 months | |
| Secondary | Service linkage outcomes | Number of visits to emergency department as assessed by Treatment History Interview (THI) | Baseline, 3 months and 6 months | |
| Secondary | Clinical outcomes | Presence of psychiatric symptoms as assessed by Altman Self-Rating Mania Scale; sum of items 1-5, with a cut off score of 6 or higher indicating presence of manic or hypomanic condition. | Baseline, 3 months and 6 months | |
| Secondary | Clinical outcomes | Severity of psychiatric symptoms as assessed by Altman Self-Rating Mania Scale; scores range from 0-20, with a cut off score of 6 or higher indicating severity of psychiatric symptoms. | Baseline, 3 months and 6 months | |
| Secondary | Clinical outcomes | Depressive symptoms as assessed by Quick Inventory of Depressive Symptoms; 16 questions, scores range from 0-27, higher scores indicating severity of depressive symptoms. | Baseline, 3 months and 6 months | |
| Secondary | Clinical outcomes | Adherence to psychotropic medications as assessed by Brief Adherence Rating Scale; more days missed indicating poor adherence. | Baseline, 3 months and 6 months | |
| Secondary | Clinical outcomes | Functioning as assessed by the 12-item WHO-Disability Assessment Schedule; scores range from 0-48, higher scores indicating greater functional impairment. | Baseline, 3 months and 6 months | |
| Secondary | Clinical outcomes | Number of hospitalizations as assessed by Treatment History Interview | Baseline, 3 months and 6 months | |
| Secondary | Clinical outcomes | Number of suicide attempts as assessed by Columbia Suicide Severity Rating Scale; scores range from 2-25, higher number indicating more intense suicidal ideation. | Baseline, 3 months and 6 months | |
| Secondary | Clinical outcomes | Substance use (alcohol) as assessed by the Alcohol Use Disorders Identification Test | Baseline, 3 months and 6 months | |
| Secondary | Clinical outcomes | Substance use (drugs) as assessed and Drug Use Disorders Identification Test | Baseline, 3 months and 6 months | |
| Secondary | Target mechanisms | Self Stigma of Mental Illness Short Form | baseline, three months and six months. | |
| Secondary | Life context outcomes | Number of nights unstably housed as measured by using calendar-based interview. | Baseline, 3 months and 6 months | |
| Secondary | Life context outcomes | Days until rearrest as measured by using calendar-based interview. | Baseline, 3 months and 6 months |